Polaris Group (TPE:6550)
37.10
-0.50 (-1.33%)
Sep 19, 2025, 1:30 PM CST
Polaris Group Revenue
Polaris Group had revenue of 8.41M TWD in the quarter ending June 30, 2025, a decrease of -73.78%. This brings the company's revenue in the last twelve months to 64.02M, down -2.31% year-over-year. In the year 2024, Polaris Group had annual revenue of 107.00M with 1,330.29% growth.
Revenue (ttm)
64.02M
Revenue Growth
-2.31%
P/S Ratio
446.51
Revenue / Employee
387.97K
Employees
165
Market Cap
28.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107.00M | 99.52M | 1,330.29% |
Dec 31, 2023 | 7.48M | 1.04M | 16.18% |
Dec 31, 2022 | 6.44M | -8.60M | -57.19% |
Dec 31, 2021 | 15.04M | 5.63M | 59.84% |
Dec 31, 2020 | 9.41M | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lumosa Therapeutics | 37.25M |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Center Laboratories | 1.60B |
Pell Bio-Med Technology | 27.43M |